Effect of intravenous iron therapy in improving hemoglobin among women after delivery of baby

Effectiveness of intravenous Ferric Carboxy Maltose (FCM) in improving haemoglobin level among postpartum women with moderate to severe anaemia at a Sub District Hospital, Faridabad, Haryana- An interventional study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014432

Enrollment

Registered

2018-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post partum women with moderate to severe anemia

Interventions

Intervention1: Single arm study: Ferric Carboxy Maltose (FCM) will be administered as intravenous infusion of 500 mg to 1000 mg dose based on requirement with 250 ml of 0.9% Normal Saline Solution wit

Eligibility

Inclusion criteria

Inclusion criteria: a.Post-partum women with hemoglobin levels 5.0 g/dl to 9.9 g/dl b.Those who give written consent and agree to cooperate for all measurements at different time points

Exclusion criteria

Exclusion criteria: a) Women with renal or hepatic impairment. b) Women having hemoglobin c) Women with history of parenteral iron administration during current pregnancy. d) Allergy to iron preparations. e) Known case of thalassemia, sickle cell anaemia or haemolytic anaemia.

Design outcomes

Primary

Measure	Time frame
To assess the change in mean haemoglobin level six weeks after intravenous administration of Ferric Carboxy Maltose (FCM) amongst postpartum women with moderate or severe anaemia who delivered at a Sub District HospitalTimepoint: six weeks	—

Secondary

Measure	Time frame
To document any adverse events following administration of FCMTimepoint: From the time of FCM administration to six weeks after intervention	—

Countries

India

Contacts

Public ContactShashi Kant

All India Institute of Medical Sciences

skant76@gmail.com9810464064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026